Form 4 for HUMA Humacyte, Inc.
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-13 · accession 0001818382-22-000212 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-15 | 2022-12-13 | HUMA | Scheessele William John | Chief Commercial Off | P - Purchase | $3.09 | +5,000 | 15.5K | +48% | +$15.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-13 | P | A | 5,000 | $3.09 | 15,525 | D | — | — |